Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-24 Purchase | 2021-11-29 08:00 am | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 3,780 | $79.33 | $299,867 | 65,678 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-18 Tax Withholding | 2024-11-20 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 4,558 | $102.89 | 67,630 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 11,750 | $0 | 83,891 (Direct) | View |
| 2024-06-24 Tax Withholding | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 2,182 | $164.64 | 83,891 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 6,250 | $0 | 83,891 (Direct) | View |
| 2024-03-08 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 909 | $123.14 | 68,073 (Direct) | View |
| 2024-03-07 Tax Withholding | 2024-03-11 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 512 | $120.49 | 68,073 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-06 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 1,728 | $125.32 | 69,494 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 778 | $126.19 | 83,722 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 18,500 | $0 | 83,722 (Direct) | View |
| 2023-11-17 Tax Withholding | 2023-11-20 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 4,508 | $82.98 | 65,751 (Direct) | View |
| 2023-03-08 Tax Withholding | 2023-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 912 | $153.19 | 70,170 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 31,500 | $0 | 98,082 (Direct) | View |
| 2023-03-06 Tax Withholding | 2023-03-08 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 1,134 | $157.21 | 98,082 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 522 | $147.57 | 67,716 (Direct) | View |
| 2022-11-17 Tax Withholding | 2022-11-21 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 4,211 | $108.52 | 67,998 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-08 8:00 pm | 2023-03-07 2032-03-07 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 56,000 | $0 | 120,111 (Direct) | View |
| 2022-03-04 Tax Withholding | 2022-03-08 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 1,216 | $79.2 | 120,111 (Direct) | View |
| 2022-03-01 Tax Withholding | 2022-03-01 8:03 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 572 | $75.05 | 65,327 (Direct) | View |
| 2021-11-16 Option Award | 2021-11-17 8:03 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer | 40,000 | $0 | 61,898 (Direct) | View |
| 2021-02-28 Tax Withholding(A) | 2021-03-10 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer | 565 | $86.97 | 21,780 (Direct) | View |
| 2021-03-03 Option Award(A) | 2021-03-10 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer | 15,000 | $0 | 21,780 (Direct) | View |
| 2021-03-03 Option Award | 2021-03-05 8:05 pm | 2022-03-03 2031-03-03 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer | 75,000 | $0 | 82,169 (Direct) | View |
| 2020-12-14 Option Award | 2020-12-14 8:05 pm | N/A 2030-12-14 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2020-12-14 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Chief Scientific Officer | 0 | $0 | 138,544 (Direct) | View |